Initial Study to Evaluate Entolimod™ for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome — an Indication for Which No Currently Approved or Stockpiled Countermeasure Has ...
On March 11, the FDA launched the Adverse Event Monitoring System (AEMS), consolidating several fragmented reporting databases into a single real-time public dashboard with artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results